87 related articles for article (PubMed ID: 1771411)
1. Neutralization of recombinant hirudin: some practical considerations.
Fareed J; Walenga JM; Hoppensteadt D; Iyer L; Pifarre R
Semin Thromb Hemost; 1991 Apr; 17(2):137-44. PubMed ID: 1771411
[No Abstract] [Full Text] [Related]
2. Anticoagulant and antithrombotic actions of recombinant hirudin.
Kaiser B
Semin Thromb Hemost; 1991 Apr; 17(2):130-6. PubMed ID: 1837615
[No Abstract] [Full Text] [Related]
3. Some objective considerations for the neutralization of the anticoagulant actions of recombinant hirudin.
Fareed J; Walenga JM; Pifarre R; Hoppensteadt D; Koza M
Haemostasis; 1991; 21 Suppl 1():64-72. PubMed ID: 1894198
[TBL] [Abstract][Full Text] [Related]
4. The comeback of hirudin as an antithrombotic agent.
Markwardt F
Semin Thromb Hemost; 1991 Apr; 17(2):79-82. PubMed ID: 1771415
[No Abstract] [Full Text] [Related]
5. The direct thrombin inhibitor hirudin.
Greinacher A; Warkentin TE
Thromb Haemost; 2008 May; 99(5):819-29. PubMed ID: 18449411
[TBL] [Abstract][Full Text] [Related]
6. Direct thrombin inhibition with Rec-hirudin CGP 39393 as prophylaxis of thromboembolic complications after total hip replacement.
Eriksson BI; Kälebo P; Ekman S; Lindbratt S; Kerry R; Close P
Thromb Haemost; 1994 Aug; 72(2):227-31. PubMed ID: 7831657
[TBL] [Abstract][Full Text] [Related]
7. Markers of hemostatic system activation during thromboprophylaxis with recombinant hirudin in total hip replacement.
Cofrancesco E; Cortellaro M; Leonardi P; Corradi A; Ravasi F; Bertocchi F
Thromb Haemost; 1996 Mar; 75(3):407-11. PubMed ID: 8701398
[TBL] [Abstract][Full Text] [Related]
8. Combined administration of barbourin--albumin and hirudin--albumin fusion proteins limits fibrin(ogen) deposition on the rabbit balloon-injured aorta.
Sheffield WP; Gataiance S; Eltringham-Smith LJ
Thromb Res; 2007; 119(2):195-207. PubMed ID: 16478628
[TBL] [Abstract][Full Text] [Related]
9. Additive effect of the combined administration of low molecular weight heparin and recombinant hirudin on thrombus growth in a rabbit jugular vein thrombosis model.
Biemond BJ; Levi M; Nurmohamed MT; Büller HR; ten Cate JW
Thromb Haemost; 1994 Sep; 72(3):377-80. PubMed ID: 7855787
[TBL] [Abstract][Full Text] [Related]
10. Development of recombinant hirudin as a therapeutic anticoagulant and antithrombotic agent: some objective considerations.
Walenga JM; Pifarre R; Hoppensteadt DA; Fareed J
Semin Thromb Hemost; 1989 Jul; 15(3):316-33. PubMed ID: 2688104
[No Abstract] [Full Text] [Related]
11. The comparative effects of recombinant hirudin (CGP 39393) and standard heparin on thrombus growth in rabbits.
Agnelli G; Pascucci C; Cosmi B; Nenci GG
Thromb Haemost; 1990 Apr; 63(2):204-7. PubMed ID: 2363121
[TBL] [Abstract][Full Text] [Related]
12. Construction and functional evaluation of hirudin derivatives with low bleeding risk.
Zhang C; Yu A; Yuan B; Dong C; Yu H; Wang L; Wu C
Thromb Haemost; 2008 Feb; 99(2):324-30. PubMed ID: 18278181
[TBL] [Abstract][Full Text] [Related]
13. A long-lasting, plasmin-activatable thrombin inhibitor aids clot lysis in vitro and does not promote bleeding in vivo.
Sheffield WP; Eltringham-Smith LJ; Gataiance S; Bhakta V
Thromb Haemost; 2009 May; 101(5):867-77. PubMed ID: 19404540
[TBL] [Abstract][Full Text] [Related]
14. Antithrombin effects of native and recombinant hirudins.
Markwardt F; Stürzebecher J; Glusa E
Biomed Biochim Acta; 1990; 49(5):399-404. PubMed ID: 2271010
[TBL] [Abstract][Full Text] [Related]
15. Hirudin versus heparin and low-molecular-weight heparin: and the winner is..
Hull RD; Pineo GF; Raskob GE
J Lab Clin Med; 1998 Sep; 132(3):171-4. PubMed ID: 9735921
[No Abstract] [Full Text] [Related]
16. Factor VIII and DDAVP reverse the effect of recombinant desulphatohirudin (CGP 39393) on bleeding in the rat.
Butler KD; Dolan SL; Talbot MD; Wallis RB
Blood Coagul Fibrinolysis; 1993 Jun; 4(3):459-64. PubMed ID: 8329573
[TBL] [Abstract][Full Text] [Related]
17. Biological relevance of anti-recombinant hirudin antibodies--results from in vitro and in vivo studies.
Liebe V; Brückmann M; Fischer KG; Haase KK; Borggrefe M; Huhle G
Semin Thromb Hemost; 2002 Oct; 28(5):483-90. PubMed ID: 12420244
[TBL] [Abstract][Full Text] [Related]
18. Effects of heparin and hirudin on thrombin generation and platelet aggregation after intrinsic activation of platelet rich plasma.
Gallistl S; Muntean W; Leis HJ
Thromb Haemost; 1995 Oct; 74(4):1163-8. PubMed ID: 8560429
[TBL] [Abstract][Full Text] [Related]
19. Unstable angina.
Natarajan M
Clin Evid; 2002 Dec; (8):225-35. PubMed ID: 12603879
[No Abstract] [Full Text] [Related]
20. Unstable angina.
Natarajan M
Clin Evid; 2002 Jun; (7):214-26. PubMed ID: 12230645
[No Abstract] [Full Text] [Related]
[Next] [New Search]